SEREN AINSWORTH: Open Payments
NPI 1356900534 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 26 payments from 13 companies in 2025. Trend: 2023 $767 · 2024 $503 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $78 |
| ABBVIE INC. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Corcept Therapeutics | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| COLOPLAST CORP | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, SPRAVATO, GEMTESA, VRAYLAR, Korlym, XIFAXAN, Titan, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
